Therapeutic options for Parkinson's disease

Drugs of Today

Volumn 38, Issue 6, 2002, Pages 445-451

  Shastry, Barkur S ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; ANTIVIRUS AGENT; BROMOCRIPTINE; CARBIDOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; TOLCAPONE;

CELL TRANSPLANTATION; DNA MICROARRAY; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; GENE THERAPY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; PARKINSON DISEASE; PATHOGENESIS; REVIEW; RISK FACTOR; SIDE EFFECT; STRIATONIGRAL DEGENERATION; SYMPTOMATOLOGY; ANIMAL; ENVIRONMENT; GENETICS; METABOLISM;

ANIMAL; CELL TRANSPLANTATION; ENVIRONMENT; GENE THERAPY; HUMAN; PARKINSON DISEASE; ANIMALS; HUMANS;

EID: 0036628111     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2002.38.6.678351     Document Type: Review

References (29)

1. Functional decline in Parkinson disease
2. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
3. Mutation analysis and association of the UCHL1 gene in German Parkinson's disease patients
4. Association between early-onset Parkinson's disease and mutations in the parkin gene
5. Progress in the clinical and molecular genetics of familial parkinsonism
6. Chronic systemic pesticide exposure reproduces features of Parkinson's disease
7. Molecular etiology of Parkinson's disease - Recent progress
8. Parkinson disease: Etiology, pathogenesis and future of gene therapy
9. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36
10. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36
11. A susceptibility locus for Parkinson's disease maps to chromosome 2p13
12. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
13. Complete genomic screen in Parkinson disease: Evidence for multiple genes
14. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
15. Association of single nucleotide polymorphism of the tau gene with late-onset Parkinson disease
16. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
17. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
18. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
19. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: A survey by the Canadian Movement Disorders Group
20. Surgical treatment of Parkinson disease
21. Science, medicine, and the future: Parkinson's disease
22. Cell therapy
23. In vitro generation and transplantation of precursor-derived human dopamine neurons
24. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease
25. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease
26. Research yields clues to improving cell therapy for Parkinson disease
27. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate model of Parkinson's disease
28. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa
29. Gene therapy for Parkinson's disease: Recent achievements and remaining challenges